HoneyLab’s fundamental value proposition is to develop scientifically robust, sustainable products with proven efficacy for treating topical conditions using pharmaceutical-grade kanuka honey and bee venom. There are a number of reasons why HoneyLab can develop strong selling OTC pharmanatural medicines, including: OTC product regulatory approvals are far easier than for prescription medicines There are no … Continue reading Investors